Review Article
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Table 1
Case reports of HCC associated with NAFLD [
7].
| Case number | Age (years) | Sex |
Comorbidity | Interval between liver disease and HCC (years) | Number/size (cm) HCC | Liver histology | Treatment | Survival |
| 1 | 52 | F | DM | 4 | Mult/— | Cirrhosis | Resection | Dead | 2 | 62 | M | DM, Ob | 4 | 1/3 | Cirrhosis | PEI | Dead | 3 | 72 | F | DM | 10 | 3/1.4 | Cirrhosis | NR | NR | 4 | 67 | F | DM | 0 | 1/2.6 | Fibrosis | Resection | NR | 5 | 66 | F | DM | 2.5 | 1/1.5 | Cirrhosis | Resection | Recurrence | 6 | 68 | F | NR | 2 | 1/2 | Cirrhosis | TAE | Alive | 7 | 69 | F | DM, Ob | 0.5 | 1/2.5 | Cirrhosis | TAI | Recurrence | 8 | 72 | M | Ob | 0 | 1/3 | Cirrhosis | TAE, PEI | Recurrence | 9 | 63 | M | DLP, Ob | 0 | 1/2 | Cirrhosis | Resection | Alive | 10 | 56 | M | DM | 0 | Mult/6 | Cirrhosis | TAE | Dead | 11 | 76 | M | DM, Ob | 10 | 1/1.9 | Cirrhosis | RFA | Alive | 12 | 74 | M | DM, Ob | 0 | 1/4 | Fibrosis | Resection | NR | 13 | 64 | M | DM, Ob | 0 | 1/— | Steatosis | TAE, resection | Alive | 14 | 67 | F | Res. Ins | 2 | 2/1.5 | Cirrhosis | TAE | Dead | 15 | 64 | M | Ob, DLP | 0 | Mult/13 | Fibrosis | NR | Dead | 16 | 70 | M | DM, Ob | 0 | 1/4.5 | Cirrhosis | TAE, resection | NR |
|
|
M: male, F: female, DM: diabetes mellitus, Ob: obese, DLP: dyslipidemia, Mult: multinodular, PEI: percutaneous ethanol injection, TAE: transarterial embolization, TAI: transarterial chemotherapy infusion, RFA: radiofrequency ablation, and NR: not reported.
|